The use of canine-specific albumin in dogs with septic peritonitis

Journal of Veterinary Emergency and Critical Care

Volumn 22, Issue 6, 2012, Pages 631-639

  Craft, Elise M ^a   Powell, Lisa L ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Colloid osmotic pressure; Fluid resuscitation; Natural colloids; Sepsis

Indexed keywords

SERUM ALBUMIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOG; DOG DISEASE; FEMALE; HYPOALBUMINEMIA; MALE; METABOLISM; MICROBIOLOGY; MORTALITY; PERITONITIS; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SPECIES DIFFERENCE;

ANIMALS; DOG DISEASES; DOGS; FEMALE; HYPOALBUMINEMIA; MALE; PERITONITIS; SEPSIS; SERUM ALBUMIN; SPECIES SPECIFICITY;

ANIMALIA; CANIS FAMILIARIS;

EID: 84870743961     PISSN: 14793261     EISSN: 14764431     Source Type: Journal    
DOI: 10.1111/j.1476-4431.2012.00819.x     Document Type: Article

References (54)

1. King LG. Postoperative complications and prognostic indicators in dogs and cats with septic peritonitis: 23 cases (1989-1992). J Am Vet Med Assoc 1994; 204(3):407-414.
2. Mazzaferro EM, Rudloff E, Kirby R. The role of albumin replacement in the critically ill veterinary patient. J Vet Emerg Crit Care 2002; 12(2):113-124.
3. Culp WT, Zeldis TE, Reese MS, et al. Primary bacterial peritonitis in dogs and cats: 24 cases (1990-2006). J Am Vet Med Assoc 2009; 234(7):906-913.
4. Ruot B, Papet I, Bechereau F, et al. Increased albumin plasma efflux contributes to hypoalbuminemia only during early phase of sepsis in rats. Am J Physiol Regul Integr Comp Physiol 2003; 284(3):R707-R713.
5. Margarson MP, Soni NC. Effects of albumin supplementation on microvascular permeability in septic patients. J Appl Physiol 2002; 92(5):2139-2145.
6. Ralphs SC, Jessen CR, Lipowitz AJ. Risk factors for leakage following intestinal anastomosis in dogs and cats: 115 cases (1991-2000). J Am Vet Med Assoc 2003; 223(1):73-77.
7. Bentley AM, Otto CM, Shofer FS. Comparison of dogs with septic peritonitis: 1988-1993 versus 1999-2003. J Vet Emerg Crit Care 2007; 17(4):391-398.
8. Goldwasser P, Feldman J. Association of serum albumin and mortality risk. J Clin Epidemiol 1997; 50(6):693-703.
9. Mueller MG, Ludwig LL, Barton LJ. Use of closed-suction drains to treat generalized peritonitis in dogs and cats: 40 cases (1997-1999). J Am Vet Med Assoc 2001; 219(6):789-794.
10. Winkler KP, Greenfield CL. Potential prognostic indicators in diffuse peritonitis treated with open peritoneal drainage in the canine patient. J Vet Emerg Crit Care 2000; 10(4):259-265.
11. Ludwig LL, McLoughlin MA, Graves TK, et al. Surgical treatment of bile peritonitis in 24 dogs and 2 cats: a retrospective study (1987-1994). Vet Surg 1997; 26(2):90-98.
12. Lanz O, Ellison G, Bellah JR, et al. Surgical treatment of septic peritonitis without abdominal drainage in 28 dogs. J Am Anim Hosp Assoc 2001; 37(1):87-92.
13. Woolfson JM, Dulisch ML. Open abdominal drainage in the treatment of generalized peritonitis in 25 dogs and cats. Vet Surg 1986; 15(1):27-32.
14. Grimes JA, Schmiedt CW, Cornell KK, et al. Identification of risk factors for septic peritonitis and failure to survive following gastrointestinal surgery in dogs. J Am Vet Med Assoc 2011; 238(4):486-494.
15. Vincent JL, Dubois MJ, Navickis RJ, et al. Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg 2003; 237(3):319-334.
16. Vincent JL. Relevance of albumin in modern critical care medicine. Best Pract Res Clin Anaesthesiol 2009; 23(2):183-191.
17. Drobatz KJ, Macintire DK. Heat-induced illness in dogs: 42 cases (1976-1993). J Am Vet Med Assoc 1996; 209(11):1894-1899.
18. McEllistrum MC, Collins JC, Powers JS. Admission serum albumin level as a predictor of outcome among geriatric patients. South Med J 1993; 86(12):1360-1361.
19. Cochrane Injuries Group. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. Cochrane Injuries Group Albumin Reviewers. BMJ 1998; 317(7153):235-240.
20. Wilkes MM, Navickis RJ. Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials. Ann Intern Med 2001; 135(3):149-164.
21. Finfer S, Bellomo R, Boyce N, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350(22):2247-2256.
22. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36(1):296-327.
23. Delaney AP, Dan A, McCaffrey J, et al. The role of albumin as a resuscitation fluid for patients with sepsis: a systematic review and meta-analysis. Crit Care Med 2011; 39(2):386-391.
24. Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med 2001; 345(8):588-595.
25. Russell JA. Management of sepsis. N Engl J Med 2006; 355(16):1699-1713.
26. Cepinskas G, Wilson JX. Inflammatory response in microvascular endothelium in sepsis: role of oxidants. J Clin Biochem Nutr 2008; 42(3):175-184.
27. Waddell LS, Brown AJ. Hemodynamic monitoring. In: Silverstein DC, Hopper K. eds. Small Animal Critical Care Medicine. St. Louis, MO: Saunders Elsevier; 2009, pp. 859-864.
28. Ernest D, Belzberg AS, Dodek PM. Distribution of normal saline and 5% albumin infusions in septic patients. Crit Care Med 1999; 27(1):46-50.
29. Aman J, van der Heijden M, van Lingen A, et al. Plasma protein levels are markers of pulmonary vascular permeability and degree of lung injury in critically ill patients with or at risk for acute lung injury/acute respiratory distress syndrome. Crit Care Med 2011; 39(1):89-97.
30. Martin GS, Moss M, Wheeler AP, et al. A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Crit Care Med 2005; 33(8):1681-1687.
31. Dubois MJ, Orellana-Jimenez C, Melot C, et al. Albumin administration improves organ function in critically ill hypoalbuminemic patients: a prospective, randomized, controlled, pilot study. Crit Care Med 2006; 34(10):2536-2540.
32. Powers KA, Kapus A, Khadaroo RG, et al. Twenty-five percent albumin prevents lung injury following shock/resuscitation. Crit Care Med 2003; 31(9):2355-2363.
33. Holbeck S, Grande PO. Effects on capillary fluid permeability and fluid exchange of albumin, dextran, gelatin, and hydroxyethyl starch in cat skeletal muscle. Crit Care Med 2000; 28(4):1089-1095.
34. Zhang WJ, Frei B. Albumin selectively inhibits TNF alpha-induced expression of vascular cell adhesion molecule-1 in human aortic endothelial cells. Cardiovasc Res 2002; 55(4):820-829.
35. Quinlan GJ, Mumby S, Martin GS, et al. Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Crit Care Med 2004; 32(3):755-759.
36. Meziani F, Kremer H, Tesse A, et al. Human serum albumin improves arterial dysfunction during early resuscitation in mouse endotoxic model via reduced oxidative and nitrosative stresses. Am J Pathol 2007; 171(6):1753-1761.
37. Kremer H, Baron-Menguy C, Tesse A, et al. Human serum albumin improves endothelial dysfunction and survival during experimental endotoxemia: concentration-dependent properties. Crit Care Med 2011; 39(6):1414-1422.
38. Mathews KA. The therapeutic use of 25% human serum albumin in critically ill dogs and cats. Vet Clin North Am Small Anim Pract 2008; 38(3):595-605, xi-xii.
39. Snow SJ, Jutkowitz AL, Brown AJ. Trends in plasma transfusion at a veterinary teaching hospital: 308 patients (1996-1998 and 2006-2008). J Vet Emerg Crit Care 2010; 20(4):441-445.
40. Mathews KA, Barry M. The use of 25% human serum albumin: outcome and efficacy in raising serum albumin and systemic blood pressure in critically ill dogs and cats. J Vet Emerg Crit Care 2005; 15(2):110-118.
41. Trow AV, Rozanski EA, Delaforcade AM, et al. Evaluation of use of human albumin in critically ill dogs: 73 cases (2003-2006). J Am Vet Med Assoc 2008; 233(4):607-612.
42. Vigano F, Perissinotto L, Bosco VR. Administration of 5% human serum albumin in critically ill small animal patients with hypoalbuminemia: 418 dogs and 170 cats (1994-2008). J Vet Emerg Crit Care 2010; 20(2):237-243.
43. Martin LG, Luther TY, Alperin DC, et al. Serum antibodies against human albumin in critically ill and healthy dogs. J Am Vet Med Assoc 2008; 232(7):1004-1009.
44. Francis AH, Martin LG, Haldorson GJ, et al. Adverse reactions suggestive of type III hypersensitivity in six healthy dogs given human albumin. J Am Vet Med Assoc 2007; 230(6):873-879.
45. Cohn LA, Kerl ME, Lenox CE, et al. Response of healthy dogs to infusions of human serum albumin. Am J Vet Res 2007; 68(6):657-663.
46. Chan DL, Freeman LM. Nutrition in critical illness. Vet Clin North Am Small Anim Pract 2006; 36(6):1225-41, v-vi.
47. Kenney EM, Rozanski EA, Rush JE, et al. Association between outcome and organ system dysfunction in dogs with sepsis: 114 cases (2003-2007). J Am Vet Med Assoc 2010; 236(1):83-87.
48. Quinlan GJ, Martin GS, Evans TW. Albumin: biochemical properties and therapeutic potential. Hepatology 2005; 41(6):1211-1219.
49. Smith CL, Ramsey NB, Parr AM, et al. Evaluation of a novel canine albumin solution in normal beagles (Abstr). J Vet Emerg Crit Care 2009; 19(suppl):A3.
50. O'Leary MJ, Koll M, Ferguson CN, et al. Liver albumin synthesis in sepsis in the rat: influence of parenteral nutrition, glutamine and growth hormone. Clin Sci (Lond) 2003; 105(6):691-698.
51. Margarson MP, Soni NC. Changes in serum albumin concentration and volume expanding effects following a bolus of albumin 20% in septic patients. Br J Anaesth 2004; 92(6):821-826.
52. Hardie EM, Jayawickrama J, Duff LC, et al. Prognostic indicators of survival in high-risk canine surgery patients. J Vet Emerg Crit Care 1995; 5(1):42-49.
53. Dominguez de Villota E, Mosquera JM, Rubio JJ, et al. Association of a low serum albumin with infection and increased mortality in critically ill patients. Intensive Care Med 1980; 7(1):19-22.
54. Chan DL, Freeman LM, Rozanski EA, et al. Colloid osmotic pressure of parenteral nutrition components and intravenous fluids. J Vet Emerg Crit Care 2001; 11(4):269-273.